TrialBritish journal of cancer2024

Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adenocarcinoma having high serum eotaxin levels (KG4/2015): an open-label, randomised, Phase 3 trial.

Jung Hyun Jo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.